| Typicality: | 0.558 |
| Saliency: | 0.455 |
| without preceding phase 2 trials | 4 | other |
| between october | 2 | temporal |
| trial → be conducted in → india | 46 |
| trial → be carried out in → india | 5 |
| negative | neutral | positive |
| 0.126 | 0.779 | 0.096 |
| Raw frequency | 51 |
| Normalized frequency | 0.455 |
| Modifier score | 0.850 |
| Perplexity | 97.865 |